Johnson & Johnson’s Kenvue consumer health business is preparing for an initial public offering of more than 151 million shares. The health care giant said late Monday that the per-share IPO price for Kenvue Inc. should range between $20 and $23. The consumer health business sells well-known products like Band-Aids, Listerine and over-the-counter medicines such as Tylenol. J&J announced in …
A late-year rush of giant global share sales led by Alibaba's $13 billion Hong Kong listing and Aramco's $26 billion initial public offering is failing to deliver an equivalent payday for equities bankers. Filings on Thursday revealed 17 banks will split up to $32.3 million for Alibaba Group's Hong Kong deal, which will raise up to $12.9 billion for the …
